Heil Sandra G, Hogeveen Marije, Kluijtmans Leo A J, van Dijken P J, van de Berg Gerard B, Blom Henk J, Morava Eva
Department of Pediatrics, Laboratory of Pediatrics and Neurology, Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
J Inherit Metab Dis. 2007 Oct;30(5):811. doi: 10.1007/s10545-007-0546-6. Epub 2007 Sep 4.
Cobalamin is an essential cofactor for two mammalian enzymes: methionine synthase and methylmalonyl-CoA mutase. Patients with the cobalamin C (CblC) defect have combined methylmalonic aciduria and homocystinuria. Recently, the gene responsible for the CblC type, MMACHC, was identified, which enables molecular diagnostics. In this study, we describe two siblings, a 16-year-old girl and her 11-year-old brother, of a consanguineous family who presented with a very distinct clinical manifestation. The girl presented at the age of 13 years with macrocytic anaemia, cognitive regression and Marfanoid features such as increased arm-span, arachnodactyly, joint hyperlaxity and scoliosis. Her brother presented at the age of 10 months with developmental delay and behavioural abnormalities. Biochemical analysis showed severely increased homocysteine and methylmalonic acid levels in plasma of both siblings. In addition, plasma cysteine levels were decreased in the girl but not in her brother. The diagnosis of CblC defect was confirmed by genomic sequencing of the coding exons of the MMACHC gene. Two heterozygous mutations were identified in both siblings; the common c.271dupA p.Arg91LysfsX14 and a novel mutation, c.1A > G p.Met1?. Therapy consisting of folic acid, vitamin B6, l-carnitine and intramuscular vitamin B12 resulted in a clear improvement of biochemical parameters and, importantly, resulted in amelioration of the Marfanoid features in the girl. These data might suggest that low cysteine levels account for the Marfanoid features observed in the girl and indicate that the CblC type of combined methylmalonic aciduria and homocystinuria should be considered in the differential diagnosis of patients with Marfanoid features.
钴胺素是两种哺乳动物酶(甲硫氨酸合成酶和甲基丙二酰辅酶A变位酶)的必需辅助因子。患有钴胺素C(CblC)缺陷的患者会出现甲基丙二酸尿症和高胱氨酸尿症。最近,确定了导致CblC型的基因MMACHC,这使得分子诊断成为可能。在本研究中,我们描述了一个近亲家庭中的两名兄弟姐妹,一名16岁女孩和她11岁的弟弟,他们表现出非常独特的临床表现。该女孩13岁时出现大细胞贫血、认知衰退以及马凡氏综合征特征,如臂展增加、蜘蛛指、关节过度松弛和脊柱侧弯。她的弟弟10个月大时出现发育迟缓及行为异常。生化分析显示,两名兄弟姐妹血浆中的同型半胱氨酸和甲基丙二酸水平严重升高。此外,女孩血浆中的半胱氨酸水平降低,而她的弟弟则未降低。通过对MMACHC基因编码外显子进行基因组测序,确诊为CblC缺陷。在两名兄弟姐妹中均鉴定出两个杂合突变;常见的c.271dupA p.Arg91LysfsX14和一个新突变c.1A>G p.Met1?。由叶酸、维生素B6、左旋肉碱和肌肉注射维生素B12组成的治疗方案使生化指标明显改善,重要的是,改善了女孩的马凡氏综合征特征。这些数据可能表明,低半胱氨酸水平是女孩出现马凡氏综合征特征的原因,并表明在对具有马凡氏综合征特征的患者进行鉴别诊断时,应考虑CblC型甲基丙二酸尿症和高胱氨酸尿症。